Sensyne Health PLC - the healthcare technology company - Signs a five year non-exclusive strategic research agreement with Somerset NHS Foundation Trust. The agreement will enable the ethical application of clinical AI research to improve patient care and accelerate research into new medicines. The Somerset dataset covers 1.1 million unique patient records from a patient population of 600,000 people.
In a separate statement, the company says following this agreement, it has achieved a major objective set at its initial public offering in August 2018 of growing its anonymised patient database to five million patients.
Current stock price: 125.00 pence
Year-to-date change: up 80%
By Evelina Grecenko; evelinagrecenko@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.